Glenn C. David
Net Worth

Last updated:

What is Glenn C. David net worth?

The estimated net worth of Mr. Glenn C. David is at least $41,170,947 as of 23 Feb 2022. He owns shares worth $7,263,835 as insider, has earned $21,667,112 from insider trading and has received compensation worth at least $12,240,000 in Zoetis Inc..

What is the salary of Glenn C. David?

Mr. Glenn C. David salary is $1,530,000 per year as Group Pres & Executive Vice President in Zoetis Inc..

How old is Glenn C. David?

Mr. Glenn C. David is 53 years old, born in 1972.

What stocks does Glenn C. David currently own?

As insider, Mr. Glenn C. David owns shares in one company:

Company Title Shares Price per share Total value
Zoetis Inc. (ZTS) Group Pres & Executive Vice President 46,572 $155.97 $7,263,835

What does Zoetis Inc. do?

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

ZTS logo
ZTS
Zoetis Inc.
$155.97

Glenn C. David insider trading

Zoetis Inc.

Mr. Glenn C. David has made 9 insider trades between 2017-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 43,778 units of ZTS stock on 5 Mar 2020. As of 23 Feb 2022 he still owns at least 46,572 units of ZTS stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option 7,712 N/A N/A
Option
Common Stock 24,678 $87.51 $2,159,572
Option
Common Stock 7,712 $46.09 $355,446
Sale
Common Stock 7,046 $188.95 $1,331,342
Option
Stock Option 24,678 N/A N/A
Sale
Common Stock 19,415 $189.95 $3,687,879
Sale
Common Stock 5,929 $190.7 $1,130,660
Option
Common Stock 6,247 N/A N/A
Option
Performance Award Unit 21,543 N/A N/A
Option
Restricted Stock Unit 6,247 N/A N/A
Option
Common Stock 21,543 N/A N/A
Option
Stock Option 26,285 N/A N/A
Sale
Common Stock 26,285 $168.78 $4,436,382
Option
Common Stock 26,285 N/A N/A
Option
Restricted Stock Unit 7,412 N/A N/A
Option
Common Stock 18,233 N/A N/A
Option
Performance Award Unit 10,821 N/A N/A
Option
Stock Option 43,778 $52.62 $2,303,598
Option
Common Stock 43,778 $52.62 $2,303,598
Sale
Common Stock 43,778 $141.03 $6,173,792
Option
Performance Award Unit 12,804 N/A N/A
Option
Common Stock 21,447 N/A N/A
Option
Restricted Stock Unit 8,643 N/A N/A
Option
Common Stock 3,044 N/A N/A
Option
Restricted Stock Unit 3,044 N/A N/A
Sale
Common Stock 16,861 $120.17 $2,026,186
Option
Common Stock 16,861 $120.17 $2,026,186
Option
Stock Option 16,861 $120.17 $2,026,186
Option
Stock Option 4,440 $120.02 $532,889
Option
Common Stock 4,440 $120.02 $532,889
Sale
Common Stock 4,440 $120.02 $532,889
Option
Common Stock 5,476 N/A N/A
Option
Restricted Stock Unit 5,476 N/A N/A
Option
Common Stock 8,191 $102.22 $837,284
Option
Stock Option 8,191 $102.22 $837,284
Sale
Common Stock 8,191 $102.22 $837,284
Option
Restricted Stock Unit 2,237 N/A N/A
Option
Performance Award Unit 3,729 N/A N/A
Option
Common Stock 5,966 N/A N/A
Option
Stock Option 16,385 $92.2 $1,510,697
Sale
Common Stock 16,385 $92.2 $1,510,697
Option
Common Stock 16,385 $92.2 $1,510,697
Option
Common Stock 4,909 N/A N/A
Option
Restricted Stock Unit 1,995 N/A N/A
Option
Performance Award Unit 2,914 N/A N/A
Option
Common Stock 4,324 N/A N/A
Option
Restricted Stock Unit 4,324 N/A N/A
Option
Common Stock 4,349 N/A N/A
Option
Restricted Stock Unit 4,349 N/A N/A

Zoetis key executives

Zoetis Inc. executives and other stock owners filed with the SEC: